Novel blister primary pack development
Development of novel blister primary packaging in parallel with device technology to unlock innovative solutions for enhanced drug delivery performance.
Using our expertise in the development of drug devices, we have innovated the design of conventional mono-dose blisters to enhance the delivery performance for a range of dry powder and aqueous drug formulations.
We develop and prove novel blister solutions through a combination of advanced analytical simulation, high-quality in-house blister prototyping and testing capability. Our cost-saving process has ensured that the development of blister containers can rapidly take place ‘under one roof’ in combination with the development of a device.